303 related articles for article (PubMed ID: 15565258)
1. Evaluation of the genotypic pattern of HIV-1 resistance in AIDS patients failing antiretroviral therapy.
Bahia F; Pedroso C; Netto EM; Figueiredo R; Pinto Neto L; Brites C
Braz J Infect Dis; 2004 Aug; 8(4):281-9. PubMed ID: 15565258
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 genotypic resistance profile of patients failing antiretroviral therapy in Paraná, Brazil.
Toledo PV; Carvalho DS; Romagnoli L; Marcinko G; Cunha CA; Souza MN; Brindeiro R; Queiroz-Telles Fd
Braz J Infect Dis; 2010; 14(4):360-71. PubMed ID: 20963321
[TBL] [Abstract][Full Text] [Related]
3. Impact of the number of failed therapeutic regimes on the development of resistance mutations to HIV-1 in northeast Brazil.
Medeiros MS; Arruda EA; Guerrant RL; Brown CC; Lima AA
Braz J Infect Dis; 2007 Oct; 11(5):451-5. PubMed ID: 17962868
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil.
Cavalcanti AM; Lacerda HR; Brito AM; Pereira S; Medeiros D; Oliveira S
Mem Inst Oswaldo Cruz; 2007 Nov; 102(7):785-92. PubMed ID: 17992369
[TBL] [Abstract][Full Text] [Related]
5. The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa.
Novitsky V; Wester CW; DeGruttola V; Bussmann H; Gaseitsiwe S; Thomas A; Moyo S; Musonda R; Van Widenfelt E; Marlink RG; Essex M
AIDS Res Hum Retroviruses; 2007 Jul; 23(7):868-78. PubMed ID: 17678469
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
[TBL] [Abstract][Full Text] [Related]
7. Study of antiretroviral mutants in HIV patients with treatment failures and the effect of risk factors in the virological failures.
Taylor-Castillo L; Herrera-Martínez G; León-Bratti MP; Boza R; León-Rodríguez B; Luftig RB; Visoná K
Rev Inst Med Trop Sao Paulo; 2005; 47(6):327-31. PubMed ID: 16553322
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy.
Aleman S; Söderbärg K; Visco-Comandini U; Sitbon G; Sönnerborg A
AIDS; 2002 May; 16(7):1039-44. PubMed ID: 11953470
[TBL] [Abstract][Full Text] [Related]
9. Geolocalization of HIV-1 subtypes and resistance mutations of patients failing antiretroviral therapy in Salvador - Brazil.
Filho AWO; Brites C
Braz J Infect Dis; 2017; 21(3):234-239. PubMed ID: 28363087
[TBL] [Abstract][Full Text] [Related]
10. Genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV/AIDS patients living in Liaoning Province, China: baseline prevalence and subtype-specific difference.
Han X; Zhang M; Dai D; Wang Y; Zhang Z; Liu J; Geng W; Jiang Y; Takebe Y; Shang H
AIDS Res Hum Retroviruses; 2007 Mar; 23(3):357-64. PubMed ID: 17411368
[TBL] [Abstract][Full Text] [Related]
11. Analysis of HIV- type 1 protease and reverse transcriptase in Brazilian children failing highly active antiretroviral therapy (HAART).
Machado DM; Fernandes SC; Succi RC; Freire WS; Pannuti CS; Gouveia AB; Levi JE; Diaz RS
Rev Inst Med Trop Sao Paulo; 2005; 47(1):1-5. PubMed ID: 15729467
[TBL] [Abstract][Full Text] [Related]
12. Emergence and genetic evolution of HIV-1 variants with mutations conferring resistance to multiple reverse transcriptase and protease inhibitors.
Cabana M; Clotet B; Martínez MA
J Med Virol; 1999 Dec; 59(4):480-90. PubMed ID: 10534730
[TBL] [Abstract][Full Text] [Related]
13. Genotype testing and antiretroviral resistance profiles from HIV-1 patients experiencing therapeutic failure in northeast Brazil.
Medeiros MS; Arruda EA; Guerrant RL; Brown C; Hammarskjold ML; Rekosh D; Lima AA
Braz J Infect Dis; 2007 Aug; 11(4):390-4. PubMed ID: 17873990
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study.
Assoumou L; Charpentier C; Recordon-Pinson P; Grudé M; Pallier C; Morand-Joubert L; Fafi-Kremer S; Krivine A; Montes B; Ferré V; Bouvier-Alias M; Plantier JC; Izopet J; Trabaud MA; Yerly S; Dufayard J; Alloui C; Courdavault L; Le Guillou-Guillemette H; Maillard A; Amiel C; Vabret A; Roussel C; Vallet S; Guinard J; Mirand A; Beby-Defaux A; Barin F; Allardet-Servent A; Ait-Namane R; Wirden M; Delaugerre C; Calvez V; Chaix ML; Descamps D; Reigadas S;
J Antimicrob Chemother; 2017 Jun; 72(6):1769-1773. PubMed ID: 28333232
[TBL] [Abstract][Full Text] [Related]
15. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.
Kakehasi FM; Tupinambás U; Cleto S; Aleixo A; Lin E; Melo VH; Aguiar RA; Pinto JA
AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1515-20. PubMed ID: 18160009
[TBL] [Abstract][Full Text] [Related]
16. Evidence for differences in the sexual transmission efficiency of HIV strains with distinct drug resistance genotypes.
de Mendoza C; Rodriguez C; Corral A; del Romero J; Gallego O; Soriano V
Clin Infect Dis; 2004 Oct; 39(8):1231-8. PubMed ID: 15486849
[TBL] [Abstract][Full Text] [Related]
17. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.
Caride E; Brindeiro R; Hertogs K; Larder B; Dehertogh P; Machado E; de Sá CA; Eyer-Silva WA; Sion FS; Passioni LF; Menezes JA; Calazans AR; Tanuri A
Virology; 2000 Sep; 275(1):107-15. PubMed ID: 11017792
[TBL] [Abstract][Full Text] [Related]
18. Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy.
Servais J; Lambert C; Fontaine E; Plesséria JM; Robert I; Arendt V; Staub T; Schneider F; Hemmer R; Burtonboy G; Schmit JC
J Clin Microbiol; 2001 Feb; 39(2):454-9. PubMed ID: 11158089
[TBL] [Abstract][Full Text] [Related]
19. Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.
de Baar MP; Janssens W; de Ronde A; Fransen K; Colebunders R; Kestens L; van der Groen G; Goudsmit J
AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1385-94. PubMed ID: 11018858
[TBL] [Abstract][Full Text] [Related]
20. Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
Di Giambenedetto S; Zazzi M; Corsi P; Gonnelli A; Di Pietro M; Giacometti A; Almi P; Trezzi M; Boeri E; Gianotti N; Menzo S; Del Gobbo R; Francisci D; Nerli A; Galli L; De Luca A;
Antivir Ther; 2009; 14(3):359-69. PubMed ID: 19474470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
